Respiratory muscle strength in hypothyroidism.

1 downloads 0 Views 1MB Size Report
Demosthenes. Bouro. M.D.,. F.C.C.P. To investigate respiratory muscle strength in patients with hypothyroidism, global respiratory muscle strength was.
Respiratory muscle strength in hypothyroidism. N M Siafakas, V Salesiotou, V Filaditaki, N Tzanakis, N Thalassinos and D Bouros Chest 1992;102;189-194 DOI 10.1378/chest.102.1.189 The online version of this article, along with updated information and services can be found online on the World Wide Web at: http://chestjournal.chestpubs.org/content/102/1/189

Chest is the official journal of the American College of Chest Physicians. It has been published monthly since 1935. Copyright1992by the American College of Chest Physicians, 3300 Dundee Road, Northbrook, IL 60062. All rights reserved. No part of this article or PDF may be reproduced or distributed without the prior written permission of the copyright holder. (http://chestjournal.chestpubs.org/site/misc/reprints.xhtml) ISSN:0012-3692

Downloaded from chestjournal.chestpubs.org by guest on July 10, 2011 © 1992 American College of Chest Physicians

Respiratory Muscle Hypothyroidism* Nikolaos Vassiliki

M. Siofaka Filaditaki,

Nikolaos

Thalassino

To investigate

M.D., Ph.D., M.D.; Nikolaos M.D.;

respiratory

muscle

assessed

by measuring

Psmox efforts. T4, and TSH

Maximum

were

replacement

measured

were

made

therapy

with

Measurements

FC.C.P; Tzanaki

Vassiliki M.D.;

Demosthenes

strength

in patients

in 43 hypothyroid

before

with

was and T3,

patients.

that the mean value of Pimax and Psmax increased after treatment. Significant change was found in the mean value ofVC, FEV1, and FVC after treatment but not in the FEV1/ FYC ratio. A highly statistically significant linear relationship was found between Pimax and TSH and between

I

is well

known

symptoms Dyspnea, breathing,

that can

airway reduced

hypercapnia,

and ‘

inspiratory

and

patients.7 Recently,

obstruction, responses respiratory

severe

patients

has been

reduction

shown

are studied

with

were

before

that

reduced in very

in few

reported

study

thyroid

to

evaluate

been

AND

METHODS

43 hypothyroid iatrogenic

patients,

myxedema.

15 with All

patients

idiopathic were

(primary) ambulatory

papillary

study.

Four

therapy

and

T3 and affects

weakness

is

Respiratory and expira102:169-194)

had

ing the patients

are shown

and TSH

were

Only

6.4

they

excluded

after

episodes

percent])

with

when

the

the

examination

Measurements technique

for T3 they

were

and heart beta

to

and

was

ofT4,

T3,

(Amerlex

The

T3

normal

52 to 196

values

ng/dl;

or those

and

illness.

Patients

their

were

who

smoking

during

related were

ofdiagnosis

disease

made long (n = 14; [33

smoked

habits

symptoms

on drugs

or metastatic

All measurements

study.

time

failure

blockers)

measurements

at the

any treatment,

patients

data regardof hypothyroid-

diagnosis

Sorin).

(eg,

any significant

performed

one year replacement

for the

clinical

and TSH,

myxedema

function

not change

show

a a

to 10 pAJ/ml.

of febrile

or sputum) were

0.6

from

did

not

mg/dl;

to 12.5 were

muscle

1. The

T4, T3, and TSH.

England,

patients

in order

and

in had

at least

Anthropometric

by radioimmunoassay

Amersham,

were

did

made

stopped

history

had

measurements,

disease. in Table

was made by medical confirmed by measuring ism

myxedema

carcinoma

before

been

Department

iatrogenic

thyroid

weeks

for metastatic

affecting

function.

Punax hypothyroidism

Endocrinology

with

be investigated

re-

respiratory

that

the

Patients

for

this

for TSH

volumes in a large number patients before and three We particularly aimed to between respiratory mus-

between

strength and that this thyroid hormone levels. present in both inspiratory reversible with treatment. (Chest 1992;

from

order.

for T4 were

was increased

Controversial data have the VC in hypothyroidism.9 this

and

which

as

conclude

recruited

(thyroxine)

these

as well

Pdi = transdiaphragmatic pressure; Pimax maximum static expiratory pressure; Pimaxmaximum static inspiratory prossure; RVresidual volume; T3triiodothyronine; T4thyroxme; ThC total lung capacity; TSllthyroid-stimulating hormono

thyroidectomy

Data

We studied 28

been

in Pdi has been

myxedema,

MATERIALS

and

has

it

TSH

and T3. We respiratory muscle linearly related to muscle weakness is tory muscles and is

consecutive

are among

pressures

and

PEmax PEmax

and

sleep-disordered to chemical stimuli,

In addition,

with

conducted

strength

Clinical

respiratory

hypothyroidism.

failure

expiratory

muscle strength and lung of ambulatory hypothyroid months after treatment. investigate the relationship cle

in

F.C.C.P

and T4,

after treatment.8 ported concerning We

of clinical

present

but this

hypothyroidism,

in three

a variety

be

M.D.;

M.D.,

amd three months after The results showed

thyroxine.

in Saksiotou,

Bouro

respiratory muscle strength mouth pressure during Pimax pressures, VC, FEV1, FVC,

global

hypothyroidism,

and

Strength

the

study

to smoking made.

and

(cough

Measurements

ofhypothyroidism,

before

therapy with T4. Three months after therapy, only 21 patients became euthyroid as estimated by the values ofTSH. The rest had a reduced value of TSH but the value did not reach the normal range. Vital capacity, FVC, and FEV, were measured by a dry spirometer (Vitalograph, Buckingham, England), and the FEV,/FVC ratio was calculated. All volumes

and

were

predicted

three

corrected

values,

months

after

to BTPS

and

the

and

replacement

expressed

FEV1/FVC

ratio

as a percentage was

of

expressed

as

a

percentage of FVC.’#{176} *Frnm

the

Department

ofThoracic

Medicine,

University

of Crete

Medical School, Heraklion, Crete, (Drs Siafakas, Tzanalds, and Bouros); and the Department ofThoracic Medicine (Drs Siafakas, Salesiotou, and Filaditaki) and Endocrinology (Dr Thalassinos), Evangelismos Hospital, Athens, Greece. Preliminary results of this study were presented at the 22nd Annual Meeting of SEPCR in Antwerp, Belgium, in 1987. This article was presented at the Annual Meeting, American Thoracic Society, 1991, Anaheim, Calif. Manuscript received June 13; revision accepted October 2. Reprint requests: Dr. Siofaka Department of Thoracic Medicine, University Hospital, Heraklion, Grcece 71110

Global Pimax

respiratory

RV and clip.

Pmax

and

Pamax

Their

was

near

mouths

maximum

muscle mouth

a metal

TLC.

were

pressures

strength The

Patients

connected

by a hard,

cylinder

was

pressures.

15 cm

long

were

assessed

Pimax

by

seated

and

rubber

with

piece.

an internal

The

mm

Paris),

one

Hg) and the other

measuring

negative

pressures

positive

pressures

(from

CHEST/102/1/JULY,1992

Downloaded from chestjournal.chestpubs.org by guest on July 10, 2011 © 1992 American College of Chest Physicians

near a nose

instrument

of 3 cm oral pressure

diameter

and a small leak (2 mm) at the distal end to minimize artifacts. The distal end was connected to two pressure

(Maxant,

wore

that measured

to the instrument stiff

measuring

measured

was

transducers

(from 0 to + 350

0 to mm

-

200 Hg).

189

Table

Data

1 -Anthropometric

Mean

and

Changes

in Weight

after

Treatment

(Mean

Sex

hypothyroidism

\%ight

No.

Male

Idiopathic

15

5

10

57.6±9.4

Jatrogenic

28

6

22

53.0±

Total

43

11

32

. . .

. . .

*No

significant

difference

tStatistically

manometers

Both

maximum Efforts the

maintained

used

mean

weight

rested

enabling

for at least was

less

when

1 s. These

efforts

5 percent

and

than

at

before

the

us to read

maximum

82.6±12.3

129.3±24.3

Before

160±7*

75.4±

121.5±20.7*

Before

± 7.8

were the

recorded

after

was

Analysis are presented

Data to

mean

values

complete paired

of the

t test.

value

statistically

data

two

before The

relationships. indicate

as mean

evaluate

groups. and

least

squares

method value

less

mean

patients

was

H20 with

Student

was than

t test

was

between

in mean

treatment

the

values

were

evaluated

used

to calculate

0.05

was

of the by

the

linear

value

considered

to

U LTS

Pimax

83 ± 25 cm

H20

after three months thyroxine. This change

1 SD

before

and

)

for

all

43

in the

PEinax

mean value of 115 ± 32 after mean

±

SD

1

of

of patients

1 . Table

2 shows

ratio,

as well and

before

After

thyroid

treatment significant

change

ment

shown

mean

and

iatrogenic)

value

levels and

of all patients (p